Physician profile
Joice Samuel
NPI 1043321003
$1,686.47
in general payments reported to CMS, 2019-2025
22 companies · $48.50 in 2025
The $48.50 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $288 · 2021: $304 · 2022: $195 · 2023: $443 · 2024: $223 · 2025: $48.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $583.21 | 2019-2024 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $343.10 | 2019-2023 | Verquvo, Steglatro, Dificid |
| Phadia US INC. | $174.65 | 2020-2024 | Immunocap |
| Amgen INC. | $69.79 | 2019-2023 | Prolia, Evenity |
| Otsuka America Pharmaceutical, INC. | $52.54 | 2021-2022 | |
| Amarin Pharma, INC. | $50.65 | 2019-2021 | |
| Genzyme Corporation | $42.94 | 2023-2024 | |
| Alk-Abello, INC | $41.84 | 2024-2025 | Neffy, Ragwitek, Grastek |
| Nestle Healthcare Nutrition INC. | $40.90 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.49 | 2021-2023 | |
| Sobi, INC | $36.05 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.08 | 2020-2022 | |
| Ars Pharmaceuticals Operations, INC. | $22.65 | 2025 | Neffy |
| Gilead Sciences, INC. | $22.03 | 2022 | |
| Hologic Sales and Service, LLC | $21.18 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $19.44 | 2023 | |
| Janssen Pharmaceuticals, INC | $19.39 | 2022 | |
| Novo Nordisk INC | $17.42 | 2023 | Ozempic |
| Cranial Technologies, INC | $17.05 | 2023 | Doc Band |
| Genentech USA, INC. | $16.79 | 2019 | |
| Becton, Dickinson and Company | $15.25 | 2021 | |
| Pfizer INC. | $15.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joice Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.